Real-world experience with Ocrelizumab in multiple sclerosis patients: Two years follow up in Qatar

Authors
Category Primary study
JournalNeurology
Year 2021
This article has no abstract
Epistemonikos ID: 2ef4a7b709e3d6d1c4eb91f58c178c4259d895b7
First added on: Feb 13, 2025